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Interaction of Nitric Oxide Synthase
with the Postsynaptic Density Protein PSD-95
and a1-Syntrophin Mediated by PDZ Domains
Jay E. Brenman,* Daniel S. Chao,* Stephen H. Gee,³ several forms of synaptic plasticity (for review, see
Schuman and Madison, 1994). To help clarify functionsAaron W. McGee,* Sarah E. Craven,*
for nNOS throughout the body, nNOSD/D mutant miceDaniel R. Santillano,* Ziqiang Wu,* Fred Huang,*
were generated with a targeted disruption of exon 2,Houhui Xia,² Matthew F. Peters,³ Stanley C. Froehner,³
which contains the predicted starter methionine codonand David S. Bredt*
(Huang et al., 1993). Initial analysis of nNOS mutant mice*Department of Physiology
suggested a complete absence of nNOS protein and²Department of Pharmaceutical Chemistry
mRNA in brain and peripheral tissues. However, residualSchool of Medicine
NOS catalytic activity was detected in brain at levels upUniversity of California at San Francisco
to 8% of that found in wild-type animals (Huang et al.,San Francisco, California 94143
1993). nNOSD/D mice suffer from hypertrophic pyloric³Department of Physiology
stenosis (Huang et al., 1993), consistent with electro-University of North Carolina at Chapel Hill
physiological studies showing that NO mediates nonad-Chapel Hill, North Carolina 27599
renergic±noncholinergic inhibitory junctional potentials
at enteric sphincters. nNOSD/D mice are significantly re-
sistant to brain injury following cerebral ischemia (HuangSummary
et al., 1994), consistent with a role for NO in this form
of excitotoxicity (Dawson et al., 1992). nNOS mutantNeuronal nitric oxide synthase (nNOS) is concentrated
mice display an increase in aggressive behavior andat synaptic junctions in brain and motor endplates in
excess and inappropriate sexual behavior (Nelson et al.,skeletal muscle. Here, we show that the N-terminus
1995).of nNOS, which contains a PDZ protein motif, interacts
Synaptic actions of NO are facilitated by subcellularwith similar motifs in postsynaptic density±95 protein
targeting of nNOS to specialized membrane structures.(PSD-95) and a related novel protein, PSD-93. nNOS
Biochemical studies indicate that nNOS partitionsand PSD-95 are coexpressed in numerous neuronal
largely with membrane-associated and cytoskeletalpopulations, and a PSD-95/nNOS complex occurs in
subcellular fractions (Hecker et al., 1994; Brenman etcerebellum. PDZ domain interactions also mediate
al., 1995). Electron microscopy identifies >80% of nNOSbinding of nNOS to skeletal muscle syntrophin, a dys-
immunoreactivity in monkey visual cortex as axonal ortrophin-associated protein. nNOS isoforms lacking a
dendritic profiles (Aoki et al., 1993). Membrane-associ-PDZ domain, identified in nNOSD/D mutant mice, do not
ated nNOS has also been identified at the sarcolemma
associate with PSD-95 in brain or with skeletal muscle
of fast-twitch skeletal muscle fibers (Kobzik et al., 1994).
sarcolemma. Interaction of PDZ-containing domains
Sarcolemmal targeting is mediated by association oftherefore mediates synaptic association of nNOS and
nNOS with the dystrophin glycoprotein complex (Bren-may play a moregeneral role in formation of macromo-
man et al., 1995). The absence of dystrophin in Du-
lecular signaling complexes.
chenne muscular dystrophy results in translocation of
nNOS from sarcolemma to muscle cytosol.
Introduction The N-terminal domain of nNOS is unique to the neu-
ronal isoform and contains a PDZ/GLGF motif of z100
Endogenous nitric oxide (NO) derives from L-arginine amino acids that is found ina diversegroup of cytoskele-
as the product of a complex enzymatic reaction cata- tal proteins and enzymes (Cho et al., 1992). Because
lyzed by a family of three NO synthase (NOS) proteins this domain mediates association of nNOS with the dys-
(Moncada and Higgs, 1993; Bredt and Snyder, 1994a; trophin complex (Brenman et al., 1995), we have now
Nathan and Xie, 1994). The neuronal isoform (nNOS or used the yeast two-hybrid system to identify interacting
type I) is prominent in neurons and also occurs in epithe- proteins. Screening a brain library demonstrates that
lial cells of lung, in secretory cells of certain endocrine the PDZ-containing domain of nNOS binds to PDZ re-
glands, and in skeletal muscle fibers (Schmidt et al., peats in postsynaptic density 95 (PSD-95) (Cho et al.,
1992; Kobzik et al., 1994). The endothelial NOS isoform 1992) and a novel related protein, PSD-93. PSD-95 is
(eNOS, type III) is abundant in all vascular endothelial coexpressed with nNOS in several neuronal populations
cells and accounts for the endothelial-derived relaxing in the developing and mature nervous system, and a
factor described by Zawadzki and Furchgott (1980). The specific PSD-95/nNOS interaction can be detected in
inducible isoform (iNOS, type II) is rapidly upregulated transfected cell lines and solubilized cerebellar mem-
in essentially all cell types following appropriate immu- branes. In skeletal muscle, we determine that associa-
nological stimuli and serves a nonspecific immune func- tion of nNOS with the sarcolemma is mediated by direct
tion (Hibbs et al., 1987). binding of nNOS to a1-syntrophin, a protein of the dys-
Physiological studies have demonstrated numerous trophin complex containing a PDZ motif (Adams et al.,
functions for neuron-derived NO. In the peripheral 1993; Adams et al., 1995). Residual catalytically active
nervous system, NO functions as a nonadrenergic± nNOS isoforms we now identify in nNOSD/D mice, which
noncholinergic neurotransmitter mediating actions of specifically lack a PDZ motif, do not interact with PSD-
autonomic motor neurons on vascular and nonvascular 95, nor do they associate with the dystrophin complex
of skeletalmuscle sarcolemma. These datademonstratesmooth muscle. In brain, NO has been implicated in
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Table 1. Interactions of nNOS and PSD-95/93 and a1-Syntrophin
Gal4 DNA Binding Hybrid Gal4 Activation Hybrid Colony Color Growth
Interactions between nNOS and PSD-95 or PSD-93
nNOS (amino acids 1±195) SV 40 (amino acids 84±708) White 2
p53 (72±390) PSD±95, PDZ1±3 (20±364) White 2
Lamin C (66±230) PSD±95, PDZ1±3 (20±364) White 2
nNOS (1±195) PSD±95, PDZ1±3 (20±364) Blue 1
nNOS (1±195) PSD±95, PDZ1±2 (20±294) Blue 1
nNOS (1±195) PSD±95, PDZ2±3 (138±364) Blue 1
nNOS (1±195) PSD±95, PDZ1 (20±144) White 2
nNOS (1±195) PSD±95, PDZ2 (138±294) Blue 1
nNOS (1±195) PSD±95, PDZ3 (291±364) White 2
p53 (72±390) PSD±93 (116±421) White 2
Lamin C (66±230) PSD±93 (116±421) White 2
nNOS (1±195) PSD±93 (116±421) Blue 1
p53 (72±390) SV 40 (84±708) Blue 1
Interaction between nNOS and a1-Syntrophin
Lamin C (66±230) a1-syntrophin (59±166) White 2
p53 (72±390) a1-syntrophin (59±166) White 2
nNOS (1±195) a1-syntrophin (59±166) Lt. Blue 1
Yeast HF7c and Y187 cells were cotransformed with expression vectors encoding various GAL4 binding domain and GAL4 activation domain
fusion proteins. Each transformation mixture was plated on two synthetic dextrose plates, one lacking tryptophan and leucine and the other
lacking tryptophan, leucine, and histidine. Growth was measured on histidine-deficient plates, and color was measured by a b-galactosidase
colorimetric filter assay (Fields and Song, 1989).
a physiological role for PDZ domain interactions in or- brain (Figures 1a and 1b) demonstrated coexpression
of nNOS and PSD-95 transcripts in several neuronalganizing proteins at synaptic membranes, and identify
one potential function for PDZ domains in PSD-95 and populations, particularly in cerebellar granule and bas-
ket cells, which have previously been shown to expressa1-syntrophin.
high densities of nNOS and PSD-95 proteins (Bredt et
al., 1990; Kistner et al., 1993). On the other hand, PSD-Results
93 occurred at highest densities in cerebellar Purkinje
neurons, complimentary to the distribution to nNOS andThe PDZ-Containing Domain of nNOS Can
PSD-95.Bind to Similar Motifs in PSD-95 and
We also compared expression of nNOS with PSD-95/to a Related Protein, PSD-93
93 during embryonic development. Using in situ hybrid-We fused the PDZ domain of nNOS (amino acids 1±195)
ization, we found that nNOS-containing cells in embry-to the DNA binding domain of GAL4 and screened a
onic day 15 (E15) rat were differentially coexpressedhuman brain library for interacting proteins using the
with either PSD-95 or PSD-93 (Figures 1c and 1d). Asyeast two-hybrid system (Fields and Song, 1989;
previously reported, transient nNOS neurons were de-Clonetech). Two families of interacting clones were iden-
tected in developing cerebral cortical plate, olfactorytified from a screen of 106 plasmids (Table 1). One family
epithelium, and sensory ganglia (Bredt and Snyder,represented isolates encoding the PDZ motifs of PSD-
1994b). In all of these neuronal groups, we found PSD-95, and the other family encoded PDZ repeats of a re-
95 mRNA. nNOS was also developmentally expressedlated novel gene product.
in certain nonneuronal cells including chromaffin cellsPSD-95 was originally identified as an abundant deter-
of the adrenal gland and secretory cellsof the submandi-gent insoluble component of brain postsynaptic density
bular gland. PSD-93 mRNA and nNOS mRNA were coex-(Cho et al., 1992). Subcellular and electron micrographic
pressed in these glands, while PSD-95, which is reportedstudies have determined that PSD-95 occurs at both
to be neuron specific (Cho et al., 1992; Kistner et al.,pre- and postsynaptic membrane specializations, simi-
1993), was absent.lar to the distribution of nNOS (Aoki et al., 1993; Kistner
Colocalization of nNOS and PSD-95 proteins waset al., 1993). PSD-95 contains three PDZ repeats, an
evaluated by immunohistochemical staining of adjacent
SH3 domain, and a region homologous to guanylate
sections from E19 rat. Within the olfactory system, both
kinase (Cho et al., 1992). Our cloning and sequencing
PSD-95 and nNOS were enriched in dendritic specializa-
of the related gene predicts a protein of 93 kDa, PSD-
tions in olfactory cilia and in axonalprocesses projecting
93, that has the same domain structure as PSD-95 and
to the olfactory bulb, which itself does not contain either
shares 60% amino acid identity (the nucleotide se-
nNOS or PSD-95 (Figures 2A±2D). nNOS also occurs in
quence of PSD-93 has been deposited in GenBank).
fetal myenteric neurons, and its absence is associated
with hypertrophic pyloric stenosis. Immunohistochemi-
nNOS and PSD-95 Are Colocalized in Adult cal analysis revealed a colocalizationof nNOS with PSD-
and Developing Neurons 95 in myenteric neurons (Figures 2E±2H). nNOS and
If the association of nNOS with PSD-95 identified in PSD-95 were similarly colocalized in embryonic cerebral
yeast is physiologically relevant, the two proteins must cortex. Staining for both proteins was enriched in the
intermediate zone and developing cortical plate, whilebe coexpressed in neurons. In situ hybridization in rat
Nitric Oxide Synthase Binding Proteins
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Figure 1. Expression of PSD-93, PSD-95,
and nNOS in Rat Brain and E15 Embryo
In situ hybridization was used to localize tran-
scripts for PSD-93 (A), PSD-95 (B), nNOS (C),
or sense control (D) in adjacent cryosections.
(a) In adult rat brain, PSD-95 occurred only
in neurons and was coexpressed with nNOS
in certain neurons in hypothalamus, hippo-
campus, and cerebellum. PSD-93 also ap-
peared to be neuron specific but had a more
restricted distribution than did PSD-95. (b) In
cerebellum, PSD-95 and nNOS were coex-
pressed in cerebellar granule cells in the
granular layer (G) and basket cells (B) in the
molecular layer. By contrast, PSD-93 was re-
stricted to Purkinjeneurons (P) of cerebellum,
which lack nNOS or PSD-95. Double labeling
with reduced nicotinamide adenine dinucleo-
tide phosphate diaphorase and in situ hybrid-
ization identified the PSD-95± and nNOS-ex-
pressing cells in molecular layer as basket
cells (data not shown). (c) In E15 embryo,
PSD-95 was found ubiquitously expressed in
differentiated central neurons, but not in neu-
ronal precursors. PSD-95 was coexpressed
with nNOS in cerebral cortical plate (CP), dor-
sal root ganglia (DRG), and neurons of the
olfactory epithelium (OE). PSD-93 was abun-
dantly expressed in neurons of spinal cord
(SC), DRG, and trigeminal nerve (V). PSD-93
was specifically coexpressed with nNOS in
secretory cells of the submandibular gland
(SG) and (d) in chromaffin cells of the devel-
oping adrenal gland, which lack PSD-95. The
signal in liver (L) seen in all samples including
control represents nonspecific hybridization
to an aberrant fold in the tissue. K, kidney; A,
adrenal gland.
lesser staining was found in the subplate region. The environment (Figure 3A). To evaluate formation of an
nNOS/PSD-95 complex inbrain, we conducted immuno-ventricular zone was devoid of staining (Figures 2I±2J).
precipitation studies. Though only a small fraction of
PSD-95 can besolubilized from brain densities with non-nNOS Interacts with the Second
PDZ Motif of PSD-95 denaturing detergents (Cho et al., 1992; Kistner et al.,
1993), we specifically immunoprecipitated an nNOS/We found that an nNOS/PSD-95 complex was immuno-
precipitated from COS cells cotransfected with expres- PSD-95 complex from cerebellum (Figures 3B and 3C),
where both proteins are coexpressed at high levels.sion vectors for nNOS and the PDZ repeats of PSD-
95, indicating that this interaction occurs in a cellular Functions for PSD-95 are largely unknown. Recent
Cell
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Figure 3. nNOS Binds to PSD-95 through PDZ Motif Interactions
(A±C) Coimmunoprecipitation of nNOS and PSD-95. (A) COS cells
were transfected with an expression construct (PSD-myc) encoding
amino acids 1±386 of PSD-95 with a 10 amino acid c-myc epitope
tag alone (lanes 1) or were cotransfected with PSD-myc and nNOS
(lanes 2). Cell homogenates were immunoprecipitated with nNOS
and probed with a monoclonal antibody to c-myc. Input 5 5% of
protein loaded onto columns. (B) Solubilized cerebellar membranes
were immunoprecipitated with antibody to PSD-95 (lanes 2) or a
nonimmune serum (lanes 1). Western blotting shows specific coim-
munoprecipitation of nNOS but not eNOS with PSD-95. (C) Identical
immunoprecipitations from cerebellar cytosol, which lacks PSD-95
but contains high concentrations of nNOS, showed that the PSD-
95 antibody (lane 2) does not directly interact with nNOS. The eNOS
blot and the nNOS blot from cerebellar cytosol were intentionally
overexposed, but failed to show specific immunoprecipitated
Figure 2. PSD-95 Colocalizes with nNOS in Developing Neurons bands. (D) Affinity chromatography demonstrates that nNOS is se-
lectively retained by an immobilized PSD-95 protein fragment (aminoImmunohistochemical staining of adjacent sagittal sections of E19
acids 1±386) fused to GST. eNOS is not retained by the PSD column.rat fetus indicates that PSD-95 (A and C) and nNOS (B and D)
Solubilized brain extracts were incubated with G-PSD or controlare colocalized in primary olfactory epithelium (OE) and in nerve
GST beads, columns were washed with buffer containing 0.5 Mprocesses projecting to the olfactory bulb (OB) (A and B, 473; C
NaCl and 1% Triton X-100, and eluted with SDS. Bound proteinsand D, 3763). In intestine (Int) of E19 rat, PSD-95 (E and G) and
were detected by Western blotting. Input 5 10%. (E) NMDA receptornNOS (F and H) are colocalized in myenteric neurons (MN) (E and
2B carboxy-terminal peptide displaces nNOS and Kv1.4 from PSD-F, 473; G and H, 1883). In E19 rat cerebral cortex, PSD-95 (I) and
95. ªPull-downº assays from brain were conducted as above con-nNOS (J)are again colocalized. Both proteins are mostconcentrated
taining 0 (lanes 6 and 7), 10 mM (lanes 4 and 5), or 30 mM (lanes 2in neuronal processes of the intermediate zone (IZ) and cell bodies
and 3) NMDA receptor peptide or 200 mM control peptide (lanes 8of the cortical plate (CP), while the ventricular zone (VZ) is devoid
and 9). Input 5 10%.of staining (943).
nNOS, whereas those lacking this region were inactive
studies show that the second PDZ motifof PSD-95 inter- (Table 1).
acts with certain ion channels in brain, including NMDA To biochemically evaluate these interactions, we gen-
receptors and voltage-gated K1 channels, that contain erated a fusion protein linking glutathione S-transferase
a carboxy-terminal tSXV consensus sequence (Kim et (GST) to the first 386 amino acids of PSD-95 (G-PSD).
al., 1995; Kornau et al., 1995). To determine which do- Solubilized brain extracts were incubated with glutathi-
main(s) of PSD-95 bind to nNOS, we engineered yeast one beads linked to GST or G-PSD. Following extensive
constructs encoding appropriate fragments of PSD-95 washing with buffer containing 350 mM NaCl and 0.5%
fused to the GAL4 activation domain. Constructs encod- Triton X-100, bound proteins were eluted with loading
buffer. Western blotting indicated selective retention ofing the second PDZ motif of PSD-95 interacted with
Nitric Oxide Synthase Binding Proteins
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nNOS to G-PSD beads (Figure 3D). eNOS, which is 60% Catalytic assays indicated that the 136 kDa nNOSb form
had activity z80% that of full-length nNOS under theseidentical to nNOS but lacks a PDZ motif, was not re-
tained by the G-PSD beads, indicating specificity of the transfection conditions (Figure 5C). Enzyme activity was
fully dependent on calcium/calmodulin and the Km forinteraction with nNOS.
Because the second PDZ motif of PSD-95 binds both arginine was similar to that of full-length nNOS from
brain. By contrast, the activity of the 125 kDa nNOSgto nNOS and to tSXV-containing ion channels, we deter-
mined whether these binding sites are independent or was z3% that of nNOS.
NOS activity in wild-type brain is highest in cerebellumoverlapping. Previous studies demonstrated that a pep-
tide, corresponding to the carboxy-terminal 9 amino (Bredt et al., 1990). By contrast, NOS activity in nNOSD/D
is highest in the striatum and lowest in the cerebellumacids of NMDA receptor type 2B, blocks interaction of
NMDA receptor with PSD-95 (Kornau et al., 1995). Simi- (Huang et al., 1993). The regional distribution of residual
nNOS isoforms in nNOSD/D brain extracts paralleled thelarly, we found that this NMDA receptor peptide potently
blocks association of nNOS with PSD-95 (Figure 3E). pattern of residual nNOS activity previously reported
(Figures 5D) (Huang et al., 1993).Half-maximal inhibition of binding was achieved at <10
mM NMDA receptor peptide, whereas control peptides
were inactive at 200 mM. As a control, we found that nNOS Isoforms Lacking a PDZ Motif Do Not
Kv1.4, a voltage-dependent K1 channel containing a Associate with PSD-95 or Brain Membranes
tSXV sequence, was displaced from PSD-95 by similar nNOSD/D mice therefore express nNOS isoforms specifi-
concentrations of NMDA receptor peptide. We also cally lacking the PDZ motifand can be used as an impor-
found that the second PDZ domain of PSD-93, ex- tant tool to determine the functions for this domain in
pressed as a GST fusion protein, binds to nNOS in a vivo. We first evaluated association of residual nNOS
manner competitive with the NMDA receptor peptide isoforms with PSD-95. nNOSproteins purified from wild-
(data not shown). type and nNOSD/D mouse forebrain were subjected to
pull-down assays as described above. Only full-length
nNOS protein containing the PDZ motif was retained byCatalytically Active nNOS Isoforms Lacking
G-PSD beads; the alternatively spliced forms in nNOSD/Da PDZ Motif Occur in nNOSD/D Mice
did not adhere to G-PSD (Figure 6A). We also comparedTo further characterize the importance of the PDZ do-
the distribution of nNOS in wild-type and nNOSD/D mousemain, we took advantage of our observation that mice
by subcellular fractionation. Brain homogenates werecarrying a targeted disruption of exon 2 of nNOS, ex-
first extracted with physiological saline, then with bufferpress residual nNOS isoforms specifically lacking the
containing 1 M KCl and 1% Triton X-100, leaving a cy-PDZ domain. nNOSD/D mice were generated by deleting
toskeletal pellet. nNOS in wild-type brain was present inthe first translated exon (Huang et al., 1993), which is
all fractions, whereasresidual nNOS isoforms in nNOSD/Dexon 2 of nNOS in both mouse and human (Hall et al.,
occurred only in the first soluble fraction (Figure 6B).1994; see below) and which encodes the PDZ motif.
Northern blotting and 59 rapid amplification of cDNA
ends/polymerase chain reaction (RACE-PCR) analyses nNOS Binds to Skeletal Muscle Syntrophin
through PDZ Interactionsdemonstrate that residual nNOS mRNAs are expressed
in brain of nNOSD/D mice resulting from alternative splic- Interaction of PDZ motifs in nNOSand PSD-95 raisedthe
possibility that the PDZ domain of syntrophin (Adams eting that skips the targeted 1.1 kb second exon (Figure
4). Interestingly, PCR and sequence analysis indicated al., 1995) represents the binding site for association of
nNOS with the dystrophin complex (Brenman et al.,that this alternative splice also occurs in wild-type mice
and represents z5% of total NOS mRNA (Figure 4C, 1995). Interaction between the PDZ-containing domains
of nNOS (amino acids 1±195) and a1-syntrophin (aminolane 2).
Western blotting of purified brain extracts identified acids 59±166) was first evaluated by the yeast two-hy-
brid system. When cotransfected, these constructs re-residual nNOSproteins of 136 and 125 kDafrom nNOSD/D
(Figure 5A, lanes 3 and 4). These 136 kDa (nNOSb) and constituted GAL4 transcriptional activity (Table 1).
To biochemically evaluate association, we first125 kDa (nNOSg) bands from nNOSD/D did not cross-
react with antibodies to eNOS or iNOS (data not shown). conducted ªpull-downº assays from skeletal muscle ex-
tracts using GST fused to the PDZ domain of nNOSFailure of previous studies to detect immunoreactive
nNOS protein in nNOSD/D was due to the use of a less (G-NOS; Brenman et al., 1995). a1-syntrophin was selec-
tively retained by this column but did not associate withpotent polyclonal antibody and a less sensitive colori-
metric detection system (Huang et al., 1993). a control GST protein column (Figure 7A; lanes 1, 3,
and 4). We previously demonstrated that dystrophin isTo determine the relationship between the two tran-
scripts identified by RACE-PCR and the two immunore- retained by a G-NOS column (Brenman et al., 1995). The
absence of dystrophin in mdx mouse results in disrup-active protein bands, COS cells were transfected with
constructs corresponding to the truncated forms found tion of the dystrophin glycoprotein complex. We there-
fore evaluated association of skeletal muscle syntrophinin nNOSD/D, that is, 59a or 59b spliced to exon 3. Transfec-
tion of the 59a±containing construct generated a promi- from mdxmouse with G-NOS. Total a1-syntrophin levels
were decreased z50% in mdx muscle, in agreementnent immunoreactive protein band of 136 kDathat comi-
grated with nNOSb from nNOSD/D brain (Figure 5B; lanes with previous findings (Butler et al., 1992). Binding of
a1-syntrophin to G-NOS was unaffected by dystrophin3 and 4). Transfection of the 59b±containing construct
yielded an nNOS band of 125 kDa (Figure 5B, lane 5). deficiency (Figure 7A; lanes 2, 5, and 6). To demon-
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Figure 4. Exons 1 and 2 of nNOS Are Alterna-
tively Spliced
(A) Northern blot analysis of brain mRNA from
wild-type (WT) and nNOSD/D mouse hybrid-
ized with a full-length nNOS cDNA probe. A
broad band of 10.5 kb is recognized in wild-
type brain and weaker bands of 11 and 9.5
kb are recognized in nNOSD/D mouse. (B and
C) RT-PCR analysis of 59 splicing of nNOS
gene. cDNA was amplified with primers 1 and
2 (lanes 1 and 2). (B) Ethidium bromide stain-
ing shows a band of 1 kb amplified from
nNOSD/D and a band of 2.2 kb from wild type.
(C) Southern hybridization with a full-length
nNOS probe shows hybridization to the ethid-
ium-stained bands. A weaker band of 1 kb
in amplifications of wild-type cDNA is also
detected by hybridization (C, lane 2). A similar
analysis using primers 3 and 4 confirm that
exon 2 sequences are only detected in wild-
type cDNA (lanes 3 and 4). (D) Nucleotide
sequences of 59 RACE-PCR products ampli-
fied from nNOSD/D brain. Predicted CTG
starter methionine in 59a is marked with an
asterisk. (E) Schematic diagram of exon
structure of nNOS isoforms (exon structure
beyond 2 is extrapolated from the human
gene [Hall et al., 1994]). The predominant
transcript in wild-type mice is shown on top.
The two transcripts detected in nNOSD/D mice
lacking exon 2 are shown below. Positions of
PCR primers, intron/exon borders, andmethi-
onine start codons are noted. Translated se-
quences within nNOS are shaded. Unique
N-terminal region of nNOSb is cross-hatched.
(F) Predicted N-terminal amino acid se-
quence of nNOS isoforms. Numbers corre-
spond to amino acid positions within mouse
nNOS.
strate association of nNOS with syntrophin in muscle vivo, we evaluated the subcellular distribution of nNOS
isoforms in nNOSD/D mouse. Skeletal muscle homoge-extracts, we conducted immunoprecipitation experi-
ments. A polyclonal antibody specific for a1-syntrophin nates were sequentially extracted with physiologic sa-
line, then 500 mM NaCl, and finally 0.5% Triton X-100.selectively precipitated nNOS from solubilized skeletal
muscle microsomes (Figure 7B). No precipitation of Following 2959 ADP agarose purification of these muscle
extracts, Western blotting indicated that only the nNOSgnNOS occurred with nonimmune antibody, and eNOS,
was not specifically precipitated by the a1-syntrophin form is expressed in muscle of nNOSD/D. This may be
due to expression of unique alternative 59 untranslatedantibody (Figure 7C).
To determine the role of the PDZ domain for associa- exons in skeletal muscle (Xie et al., 1995). nNOS in skele-
tal muscle runs as a doublet due to a 102 bp (34 aminotion of nNOS with sarcolemmal dystrophin complexes in
Nitric Oxide Synthase Binding Proteins
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Figure 6. nNOS Isoforms Lacking the PDZ Motif Do Not Bind to
PSD-95 or to Brain Membranes
(A) Partially purified nNOS protein from wild-type (WT) or nNOSD/D
brain were analyzed by PSD ªpull-downº assay. Full-length nNOS
binds to PSD-95 while the residual isoforms lacking the PDZ motif
do not. Input 5 20%. (B) Residual nNOS isoforms are restricted to
cytosol of nNOSD/D. Brain homogenates, extracted with 100 mM
NaCl (lanes 1), 1 M KCl 1 1% Triton X-100 (lanes 2) or insoluble
pellet (lanes 3), from wild-type (20 mg/lane) or nNOSD/D (200 mg/lane)
were probed by Western blotting.Figure 5. Catalytically Active nNOS Isoforms Lacking Exon 2 Are
Expressed in Brain of nNOSD/D
(A) Western blotting of crude (lanes 1 and 2) and 2959-ADP affinity-
acid) alternative splice near the middle of the genepurified (lanes 3 and 4) brain extracts indicates that the major nNOS
(H. Xia et al., unpublished data). Importantly, subcellularband in wild-type brain migrates at 160 kDa (lanes 1 and 3), whereas
fractionation indicated that nNOSg was restricted to sol-in nNOSD/D, copurifying bands of 125 and 136 kDa (lanes 2 and 4) are
recognized. Partial tryptic digestion of 2959-ADP agarose-purified uble fractions of skeletal muscle (Figure 7E), contrasting
proteins reveals a similar proteolytic ªfingerprintº from wild type with the soluble/particulate distribution of full-length
(lane 5) and nNOSD/D (lane 6). Note that 20-fold more protein was nNOS in muscle (Figure 7D).
loaded from nNOSD/D (lanes 2, 4, and 6) than from wild-type samples
Protein overlay assays were performed to evaluate(lanes 1, 3, and 5). (B) cDNA clones encoding nNOS, nNOSb (59a
association of nNOS with individual domains of a1-syn-spliced to exon 3), or nNOSg (59b spliced to exon 3) were transfected
trophin. The three known syntrophins (a1, b1, and b2)(trx) into COS cells, and protein extracts were resolved by SDS±
PAGE. Full-length NOS (nNOS-trx) comigrates at 160 kDa with the have a common domain structure consisting of two
major product from wild-type brain (lanes 1 and 2). Transfection of Pleckstrin homology (PH) domains, a PDZ domain and
nNOSb and nNOSg yields proteins of 136 and 125 kDa, respectively, a carboxy-terminal domain unique to syntrophins (SU,
that comigrate with immunoreactive bands from nNOSD/D (lanes 3±5).
syntrophin unique). Figure 8A shows the interaction be-(C) NOS catalytic activity of nNOS isoforms. COS cells were
tween the nNOS±GST (1±299) fusion protein and the fourtransfected with 10 mg of expression vector encoding full-length
a1-syntrophin domain fusion proteins, PH1, PDZ, PH2,nNOS, nNOSb, or nNOSg.NOS activity was measured in cell homog-
enates three days following transfection in the presence of 200 and SU. Notably, only PDZ associates with nNOS. More-
mM free calcium. This experiment was replicated twice with similar over, no prominent bands were detected when the do-
results. (D) nNOS isoforms are discretely expressed in nNOSD/D mains were overlayed with GST alone. Syntrophin do-
brain. Highest densities of nNOS in wild type (10 mg/lane) are found
main fusion proteins (containing the T7´Tag epitope)in cerebellum (Cb). In nNOSD/D (100 mg/lane) highest levels of nNOS
were also used to overlay GST and nNOS±GST (Figureisoforms are found in striatum (St) and hippocampus (Hi), lower
8B). Again, only the PDZ domain of a1-syntrophin boundamounts are found in brainstem (Bs) and cerebral cortex (Cx) while
the cerebellum is devoid of nNOS isoforms in nNOSD/D. (E) eNOS is to nNOS, and no binding was observed to GST alone.
homogeneously distributed in forebrain (Fb), cerebellum (Cb), as
well as the peripheral tissues liver (Li), lung (Lu), and kidney (Ki). Discussion
All lanes in (C) were loaded with 100 mg of solubilized membrane
extract.
The PDZ consensus sequence is present in a diverse
family of enzymes and structural proteins. Many of these
Cell
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Figure 7. a1-Syntrophin Binds to the N-terminal PDZ Containing
Domain of nNOS
(A) ªPull-downº assays of solubilized muscle extracts from wild-
type or mdx mouse using an nNOS (amino acids 1±299)-GST fusion Figure 8. Direct Binding of nNOS to a1-Syntrophin PDZ Domain
protein were done as described in Figure 5. Western blotting shows
(A) Purified a1-syntrophin PH1 (25 kDa; lanes 1), PDZ domain (15
that a1-syntrophin from both wild-type and mdx mouseis selectively
kDa; lanes 2), PH2 (18 kDa; lanes 3), and SU domain (16 kDa; lanes
retained by the G-NOS column. Input 5 20%. (B and C) Immunopre-
4) fusion proteins were resolved and overlayed with GST or nNOS
cipitation of solubilized muscle extracts with a polyclonal antibody
(1±299)-GST. The position and relative amounts of the a1-syntrophin
to a1-syntrophin shows coprecipitation of (B) nNOS but not (C) domain fusion proteins are indicated by immunoreactivity with a
eNOS (lanes 2). Control experiments with nonimmune serum show monoclonal against the T7´Tag. Bound GST fusion proteins were
no precipitation of nNOS or eNOS (lanes 1). Bands at 55 kDa repre- detected by blotting with a monoclonal antibodyto GST. Only nNOS-
sent immunoglobulin heavy chains. (D and E) Subcellular fraction- GST bound specifically to the PDZ domain of a1-syntrophin. (B)
ation of nNOS is altered nNOSD/D mouse muscle. Homogenizedmus- GST (lanes 1) andnNOS-GST (lanes 2) were separated and overlayed
cle was sequentially extracted in buffer containing 100 mM NaCl with a1-syntrophin domain fusion proteins (PH1, PDZ, or PH2) or
(lanes 1), 500 mM NaCl (lanes 2), and 500 mM NaCl 1 1% Triton blotted with a monoclonal antibody to GST. Bound syntrophin fusion
X-100 (lanes 3). These extracts were purified by 2959-ADP agarose proteins were detected with monoclonal antibody to T7´Tag. Of the
chromatography and were resolved by SDS±PAGE. (D) nNOS is syntrophin fusion proteins tested, only PDZ bound to nNOS; no
present in both soluble and membrane-associated fractions of wild- binding to GST was detected. (C) Colocalization of nNOS and a1-
type mouse, whereas (E) nNOS isoforms in nNOSD/D are restricted
syntrophin immunofluorescence at skeletal muscle sarcolemma and
to the cytosol.
neuromuscular junctions (labeled by rhodamine a-bungarotoxin).
(D) Schematic model showing interaction of nNOS with skeletal
muscle a1-syntrophin (59K syn). The possibility that other enzymes
containing a PDZ motif may also bind to syntrophins is indicted at
proteins are found concentrated at specialized cell±cell the left with question marks. DG, dystroglycan.
junctions, such as neuronal synapses, epithelial zona
occludens, and septate junctions. These observations
have motivated suggestions that PDZ domains may par- the PDZ domain of a1-syntrophin explains the observed
association of nNOS with sarcolemmal dystrophin com-ticipate in protein±protein interactions at the plasma
membrane (Cho et al., 1992). Our results support this plexes (Brenman et al., 1995). We also find that nNOS
and a1-syntrophin share a similar distribution in skeletalidea and suggest that PDZ domains may be important
elements in interactions required for signal transduction muscle fast fibers (Figure 8C). The association of nNOS
and a1-syntrophin may also account for the absence ofat the membrane.
The demonstration that nNOS directly interacts with nNOS from skeletal muscle sarcolemma in Duchenne
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muscular dystrophy (Brenman et al., 1995). The three have altered subcellular distribution. We find that these
known isoformsof syntrophin (Adams et al., 1993; Ahn et isoforms do not adhere to PSD-95 from brain synaptic
al., 1994; Yang et al., 1994) each have a defined domain densities, nor do they associate with the dystrophin
structure (Adams et al., 1995). The first PH domain, complex in skeletalmuscle. This demonstrates a primary
which begins near the N-terminus, is split by an insert role for the PDZ domain in mediating subcellular local-
that contains the PDZ domain. A second PH domain is ization of nNOS. Pyloric stenosis in nNOSD/D mice (Huang
followed by a highly conserved C-terminal domain with et al., 1993) may therefore be due to dyslocalization of
apparently no homology to known proteins. Although nNOS, as we find that residual nNOS occurs at 5%±10%
the binding site for dystrophin has not been definitively of normal levels in myenteric neurons of the mutant
identified, recombinant fragments of b1-syntrophin be- mice (J. E. Brenman et al., unpublished data). Behavior
ginning just downstream of the PDZ domains bind dys- abnormalities of nNOSD/D mice (Nelson et al., 1995) may
trophin and other members of the dystrophin protein also be due to misexpression rather than lack of nNOS.
family (Ahn and Kunkel, 1995). Since the syntrophins Binding interactions between PDZ domains are selec-
have highly conserved domain structures, the location tive. Though nNOS binds to the PDZ motif in a1-syn-
of the dystrophin binding site is likely to be the same in trophin and to the second PDZ motif of PSD-95, nNOS
all three syntrophins. Thus, the binding sites for nNOS does not associate with the first or third PDZ motifs in
and dystrophin appear to lie in distinct regions of a1- PSD-95. Certain PDZ domains are capable of binding
syntrophin. Together, these studies define syntrophin to the extreme C-terminus of a family of receptors and
as a modular adapter protein linking a signaling enzyme, ion channels, including NMDA receptors (Kim et al.,
nNOS, to the sarcolemmal dystrophin complex. A model 1995), Shaker-type K1 channels (Kornau et al., 1995),
depicting these interactions is shown in Figure 8D. and Fas, a receptor involved in the induction of
Other proteins containing PDZ domainsare likely to be apoptosis (Sato et al., 1995). These studies identify a
recruited to the dystrophin complex through association C-terminal consensus tSXV that interacts with the sec-
with syntrophins. It will be of particular interest to iden- ond PDZ motif in PSD-95 and with the third PDZ motif
tify proteins that bind to the PDZ domains of b1- and of a protein tyrosine phosphatase, FAP-1, but not with
b2-syntrophin. Since the latter is highly localized to the the PDZ motif of nNOS (Kornau et al., 1995).
neuromuscular postsynaptic membrane, it seems likely We find that the PDZ domain of nNOS and the tSXV
that proteins specifically associated with the PDZ do-
motif of NMDA receptors compete for common or
main of b2-syntrophin will be important in synaptic sig-
nearby binding sites within the second PDZ repeat of
naling. nNOS is enriched in fast-twitch muscle fibers in
a PSD-95 subunit. However, PSD-95 can mediate K1
rat while a1-syntrophin is found in both fast and slow
channel clustering and likely occurs as an oligomeric
fibers. Therefore, depending on the muscle type, only
complex (Kim et al., 1995). The binding of nNOS and
a small fraction of a1-syntrophin may be associated with
NMDA receptors to distinct PSD-95 subunits in such anNOS, thus allowing for interactions with other PDZ-
complex may contribute to the well-described functionalcontaining proteins.
coupling of NMDA receptors to NOS activity in cerebel-In brain, membrane association of nNOS does not
lum and forebrain (Garthwaite, 1991). Membrane perme-require dystrophin (Brenman et al., 1995). Instead, we
ant compounds that block association of nNOS withfind that nNOS binds to the second PDZ repeat of PSD-
PSD-95 might therefore serve as novel therapeutics,95, and a related protein PSD-93. nNOS and PSD-95
as neuron-derived NO, associated with NMDA receptorare coexpressed in numerous populations of developing
activity, mediates brain injury following cerebral isch-and mature neurons, and a PSD-95/nNOS complex can
emia (Huang et al., 1994).be identified in solubilized cerebellar membranes. Fur-
ther evidence that the nNOS/PSD-95 interaction is phys-
iological derives from electron micrographic studies Experimental Procedures
showing that 83% of nNOS immunoreactive profiles in
Antibodies and Western Blottingcerebral cortex occur in pre- and postsynaptic special-
The following primary antibodies were used: nNOS1 polyclonalizations of axon terminals and over thick postsynaptic
raised against homogenous nNOS protein purified from rat cerebel-densities (Aoki et al., 1993), similar to the distribution of
lum (Bredt et al., 1990), nNOS monoclonal (Transduction Labs),PSD-95 (Cho et al., 1992; Kistner et al., 1993). nNOS
eNOS monoclonal (Transduction Labs), iNOS monoclonal (Trans-
also occurs in certain nonneuronal cells, including devel- duction Labs), a1-syntrophin polyclonal (Peters et al., 1994), PSD-
oping chromaffin cells of the adrenal gland and secre- 95 polyclonal (Cho et al., 1992), Kv1.4 polyclonal (Kim et al., 1995),
tory cells of salivary gland. In these cells, nNOS is c-myc monoclonal (9E10; BABCO), T7´Tag monoclonal and GST
12 monoclonal (Santa Cruz Biotechnology). For Western blotting,coexpressed with PSD-93, but not PSD-95. Definitive
protein extracts were resolved by SDS-polyacrylamide gel electro-evidence that nNOS physiologically associates with
phoresis and transferred to PVDF membranes. Primary antibodiesPSD-93 in these glands will require development of anti-
were diluted in block solution containing 3% bovine serum albumin,sera for coimmunoprecipitation studies in vivo.
0.1% Tween 20 in Tris-buffered saline and incubated with mem-
The importance of the PDZ domain of nNOS is further branes overnight at 48C. Labeled bands were visualized using en-
revealed by our studies of nNOSD/D mouse. This work hanced chemiluminescence (Amersham). All nNOS Western blots
indicates that the residual NOS activity in brain of these used nNOS monoclonal.
mutants results from alternative splicing that skips the
targeted second exon of nNOS. This alternative splicing In Situ Hybridization
also occurs at low levels in wild-type mice and results In situ hybridization used 35S-labeled RNA probes exactly as de-
in truncated nNOS proteins lacking the PDZ motif en- scribed (Sassoon and Rosenthal, 1993). Antisense probes to nNOS
(nucleotides 4119±5057), PSD-95 (1±1155), PSD-93 (237±927) orcoded inexon 2. nNOS isoforms lacking thePDZ domain
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sense control PSD-93 (237±927) were synthesized from Bluescript purified from urea-solubilized inclusions. Fusionproteins were sepa-
rated on 15% SDS±PAGE gels, transferred to nitrocellulose mem-vectors.
branes, blocked with 5% skim milk in 25 mM Tris (pH 7.5), 150 mM
NaCl, and 0.1% Tween-20 (Tris-buffered saline/Tween) and incu-Immunohistochemistry
bated with purified fusion proteins (20 mg/ml) in this buffer for 1 hrRats were perfused with 4% paraformaldehyde, tissues were har-
at 258C. Blots were washed 33 10 min in Tris-buffered saline/Tween,vested, postfixed at 48C for 3 hr, and cryoprotected in 20% sucrose
incubated with primary antibody T7´Tag or GST 12 for 30 min andovernight. Sections (20 mm) were cut on a cryostat and melted onto
bands visualized by enhanced chemiluminescence.glass slides (Plus, Fisher). Sections were then blocked for 1 hr in
buffer containing 2% goat serum, 0.1% Triton X-100 in phosphate-
buffered saline. Primary antibodies to nNOS (polyclonal nNOS), mRNA Isolation and cDNA Analysis
PSD-95, or a1-syntrophin were diluted into blocking reagent and RNA was isolated using the guanidine isothiocyanate/CsCl method,
incubated with sections overnight. Immunoperoxidase histochemis- and mRNA was selected using oligo dT sepharose. For Northern
try was performed using the ABC method (Vector). Immunofluores- blotting, mRNA was separated on a formaldehyde agarose gel and
cent staining of rat extensor digitorum longus muscle was done as transferred to a Nylon membrane. A random-primed 32P probe was
described (Brenman et al., 1995). Control sections lacking primary generated using the full-length (5057 bp) nNOS cDNA (Bredt et al.,
antisera were stained in parallel. 1991) as a template. The filter was washed at high stringency, 688C,
0.1% sodium chloride/sodium citrate, 0.1% SDS and exposed to
X-ray film overnight at 2708C.Cell Culture and Transfection
Thermal RACE-PCR was performed as described (Frohman,Neuronal NOS cDNAs were cloned into the EcoRV and XbaI sites
1993). The sequences of the nNOS-specific primers in exon 3 wereof the mammalian expression vector pcDNA 3 (Invitrogen). 59a± and
as follows: Race 1, CCACAGATCATTGAAGACTCG; Race 2, GGGGA59b±containing constructs were amplified by PCR, sequenced, and
ATTCCCCGCCCAGGGGCGGAGCTTT.cloned into the unique NarI restriction site of nNOS. PSD-95-myc
For RT±PCR, mRNA was reverse transcribed with RTth polymer-construct (amino acids 1±386 with a C-terminal myc-epitope tag)
ase using random hexamer primers. The sequences of the PCRwas amplified by PCR and cloned into the BamHI and EcoRI sites
primers used were as follows: P1, GTCCCTGCGTATTGATGCA; P2,of pcDNAIII. Monkey COS cells were grown and transfected using
GGCCGACCTGAGATTCCC; P3, CTCTGCATCTGTCAAGCTGG; P4,calcium phosphate as previously described (Bredt et al., 1991). Two
CCTTCACCAGGAAGCCCAGA.days following transfection, cells were washed with phosphate-buf-
Clones encoding PSD-93 were isolated from a rat brain cDNAfered saline, harvested in 2 ml of buffer containing 25 mM Tris±HCl
library (Stratagene) by plaque hybridization.(pH 7.4), 100 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM phenylmeth-
ylsulfonyl fluoride and disrupted using a polytron.
nNOS Protein Purification and Catalytic Assays
Solubilized tissue homogenates were incubated with 100 ml of 2959-Immunoprecipitations
ADP agarose (Sigma); columns were washed with 5 ml of bufferRat cerebellum was homogenized in 20 vol of buffer containing 25
containing 0.35M NaCl and wereeluted with 10 mM reduced nicotin-mM Tris (pH 7.5), 150 mM NaCl and centrifuged at 100,0003 g
amide adenine dinucleotide phosphate. Catalytic NOS activity wasto yield cytosol. Cerebellar membranes were solubilized with 1%
quantitated by monitoring the conversion of [3H]arginine to [3H]citrul-digitonin and 100 mM NaCl and centrifuged to remove the insoluble
line as described (Bredt and Snyder, 1990).cytoskeleton. PSD-95 polyclonal antiserum to PSD-95 (3 ml) or non-
immune serum (3 ml) was added to 1 ml (500 mg) of cerebellar cytosol
or solubilized membranes. After a 60 min incubation on ice, 50 ml Acknowledgments
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